CXorf21, a protein encoded by the CXorf21 gene, is subject to regulation by several chemical activators that manipulate different signaling pathways to modulate its activity. One class of activators works by elevating intracellular cyclic AMP (cAMP), a pivotal secondary messenger in various signaling cascades. The increase in cAMP levels by these activators stimulates adenylyl cyclase or inhibits phosphodiesterases, leading to an amplified cascade of phosphorylation events. This cascade is known to regulate a variety of cellular functions, and in the context of CXorf21, it can increase the protein's activity through phosphorylation-dependent mechanisms. Additionally, certain analogs of cAMP can permeate cellular membranes and directly activate cAMP-dependent pathways, thereby potentially enhancing the functional activity of CXorf21 by mimicking the action of endogenous cAMP.
Another set of chemical activators affects CXorf21 activity by modulating intracellular calcium concentrations. These activators, including ionophores and receptor agonists, facilitate the influx of calcium ions into the cell or bind to receptors that trigger calcium release from intracellular stores. The elevated intracellular calcium can activate calcium-dependent signaling pathways, which are known to influence various cellular processes, including those that CXorf21 may be involved in. Concurrently, activators that target protein kinase C can further impact CXorf21 activity by initiating signaling events downstream of calcium mobilization. This intricate network of signaling, involving secondary messengers like cAMP and calcium, orchestrates the cellular conditions that can lead to the enhanced activity of CXorf21.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increases cAMP and cGMP by preventing their degradation, potentially enhancing CXorf21 activity through cAMP-dependent pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Cell-permeable cAMP analog that activates cAMP-dependent pathways, potentially increasing CXorf21 activity by mimicking the action of endogenous cAMP. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Activates G-protein coupled receptors which can increase intracellular cAMP, potentially resulting in enhanced CXorf21 activity through cAMP-mediated signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that raises intracellular calcium levels, potentially influencing CXorf21 activity through calcium-dependent signaling mechanisms. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium, potentially affecting CXorf21 activity via calcium signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C (PKC) which could enhance CXorf21 activity through PKC-mediated signaling pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Adrenergic receptor agonist which increases cAMP levels, potentially leading to increased CXorf21 activity via cAMP-dependent signaling. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Binds to G-protein coupled receptors and can increase intracellular calcium, potentially affecting CXorf21 activity through calcium-mediated pathways. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Activates TRPV1 which can increase intracellular calcium, potentially affecting CXorf21 activity via calcium signaling pathways. | ||||||